| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |